Occipital Nerve Stimulation Corporate Medical Policy

Similar documents
Occipital Nerve Stimulation Corporate Medical Policy

Gastric Electrical Stimulation Corporate Medical Policy

Occipital Nerve Stimulation

Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy

Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus and Colon Corporate Medical Policy

Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures Corporate Medical Policy

Nonpharmacologic Treatment of Rosacea Corporate Medical Policy

Pediatric Neurodevelopmental and Autism Spectrum Disorder (ASD) Screening Corporate Medical Policy

Policy #: 411 Latest Review Date: January 2014

Ambulatory Cardiac Monitors and Outpatient Telemetry Corporate Medical Policy

Cochlear Implant Corporate Medical Policy

External Insulin Pumps Corporate Medical Policy

Original Policy Date

Medical Policy. Description/Scope. Position Statement. Rationale

Bariatric Surgery Corporate Medical Policy

Corporate Medical Policy Gastric Electrical Stimulation

NUTRITIONAL COUNSELING Corporate Medical Policy

Prostatic Urethral Lift Corporate Medical Policy

Continuous or Intermittent Glucose Monitoring (CGMS) in Interstitial Fluid Corporate Medical Policy

Dry Needling of Myofascial Trigger Points Corporate Medical Policy

NUTRITIONAL COUNSELING Corporate Medical Policy

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Occipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache

Corporate Medical Policy

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Peripheral Subcutaneous Field Stimulation

Enteral Nutrition Corporate Medical Policy

Chemical Peels Corporate Medical Policy

Headache: Using Neuromodulation as Therapy

Peripheral Subcutaneous Field Stimulation. Description

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation

Medical Policy Manual. Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April Section: Surgery Last Reviewed Date: April 2014

2016 HF10 THERAPY REIMBURSEMENT REFERENCE GUIDE

HF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide

Corporate Medical Policy

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

Enteral Nutrition Corporate Medical Policy

Nevro Reimbursement Support

Corporate Medical Policy

Corporate Medical Policy

H F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E

All Indiana Health Coverage Programs Hospitals, Ambulatory Surgical Centers, Physicians, and Durable Medical Equipment Providers

Gastric Electrical Stimulation

tens_(transcutaneous_electrical_nerve_stimulator) 7/ / / /2014 This policy is NOT effective until January 13, 2015

Treatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation

Inspire Medical Systems. Physician Billing Guide

Long-Term Outcome in Occipital Nerve Stimulation Patients With Medically Intractable Primary Headache Disorders

MEDICAL POLICY I. POLICY II. PRODUCT VARIATIONS TOP III. DESCRIPTION/BACKGROUND POLICY TITLE SPHENOPALATINE GANGLION BLOCK POLICY NUMBER MP-4.

Hippotherapy Corporate Medical Policy

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy

2 016 HF10 THERAPY HOSPITAL OUTPATIENT DEPARTMENT AND AMBULATORY SURGERY CENTER REIMBURSEMENT REFERENCE GUIDE

Subject: Gastrointestinal Electrical Stimulation (GES) and Vagus Nerve Blocking Therapy (VBLOC) for Obesity. Original Effective Date: 7/8/2015

Corporate Medical Policy

Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)

Clinical Policy: Vagus Nerve Stimulation Reference Number: PA.CP.MP.12

Corporate Medical Policy

Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses Corporate Medical Policy

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy

ABBOTT CODING GUIDE CHRONIC PAIN. Effective January 1, 2019 INTRO SPINAL CORD STIMULATION (SCS) RADIOFREQUENCY ABLATION (RFA)

Corporate Medical Policy

Inspire Medical Systems. Hospital Billing Guide

Vagus Nerve Stimulation (VNS)

PERCUTANEOUS TIBIAL NERVE STIMULATION

Corporate Medical Policy

Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses Corporate Medical Policy

MEDICAL POLICY SUBJECT: GASTRIC ELECTRICAL STIMULATION

Highmark Medical Policy Bulletin

Allergy Testing Corporate Medical Policy

PERCUTANEOUS TIBIAL NERVE STIMULATION

Continuous Passive Motion in the Home Setting Corporate Medical Policy

Corporate Medical Policy

Neuromodulation Therapy. Description

Peripheral Neuromodulation and Headaches: History, Clinical Approach, and Considerations on Underlying Mechanisms

Corporate Medical Policy

Dermatologic Applications of Photodynamic Therapy Corporate Medical Policy

Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients

Sustained Effectiveness of Occipital Nerve Stimulation in Drug-Resistant Chronic Cluster Headachehead_

Affiliation: 1- Departments of Anesthesiology/ Pain Management and Neurology, UCSF School of Medicine 2- Thrive Clinic, LLC, Santa Rosa, CA

Phenotype of patients responsive to occipital nerve stimulation for refractory head pain

MEDICAL POLICY SUBJECT: VAGUS NERVE STIMULATION

Corporate Medical Policy

Corporate Medical Policy Tumor-Treatment Fields Therapy for Glioblastoma

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133

Corporate Medical Policy Automated Percutaneous and Endoscopic Discectomy

Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery

External Insulin Pumps Corporate Medical Policy

Corporate Medical Policy

Name of Policy: Sympathetic Therapy and Bioelectrical Nerve Block or Electroanalgesic Nerve Block for the Treatment of Pain

Clinical Policy: Vagus Nerve Stimulation

03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and

SPINAL CORD AND IMPLANTABLE PERIPHERAL NERVE STIMULATORS Version 18.0; Effective

PAIN MANAGEMENT CODES PRIOR AUTHORIZATION REQUIRED THROUGH EVICORE HEALTHCARE

1. POLICY: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor

Applied Behavior Analysis (ABA) Corporate Medical Policy

Transcription:

Occipital Nerve Stimulation Corporate Medical Policy File Name: Occipital Nerve Stimulation File Code: UM.SPSVC.14 Origination: 2011 Last Review: 06/2018 Next Review: 06/2019 Effective Date: 10/01/2018 Description/Summary Occipital nerve stimulation (ONS) delivers a small electrical charge to the in an attempt to prevent migraines and other headaches in patients who have not responded to medications. The device consists of a subcutaneously implanted pulse generator (in the chest wall or abdomen) attached to extension leads that are tunneled to join electrodes placed across 1 or both s at the base of the skull. Continuous or intermittent stimulation may be used. Policy Occipital nerve stimulation is considered investigational for all indications. Coding Information Click the links below for attachments, coding tables & instructions. Attachment I- CPT & Code Table & Instructions Reference Resources 1. Blue Cross and Blue Shield Association. Occipital Nerve Stimulation. MPRM# 7.01.125. Last review April 2018. 2. Chen YF, Bramley G, Unwin G, et al. Occipital nerve stimulation for chronic migraine--a systematic review and meta-analysis. PLoS One. 2015;10(3):e0116786. PMID 25793740 3. Yang Y, Song M, Fan Y, et al. Occipital nerve stimulation for migraine: a systematic review. Pain Pract. Apr 2016;16(4):509-517. PMID 25865962 4. Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. Feb 2011;31(3):271-285. PMID 20861241 5. Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the s for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. Dec 2012;32(16):1165-1179. PMID 23034698 6. Dodick DW, Silberstein SD, Reed KL, et al. Safety and efficacy of peripheral nerve Page 1 of 6

stimulation of the s for the management of chronic migraine: long-term results from a randomized, multicenter, doubleblinded, controlled study. Cephalalgia. Apr 2015;35(4):344-358. PMID 25078718 7. Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. Nov 2008;7(11):1001-1012. PMID 18845482 8. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by stimulation in 14 patients. Neurology. Jan 27 2009;72(4):341-345. PMID 19171831 9. Magis D, Gerardy PY, Remacle JM, et al. Sustained effectiveness of stimulation in drug-resistant chronic cluster headache. Headache. Sep 2011;51(8):1191-1201. PMID 21848953 10. Mueller OM, Gaul C, Katsarava Z, et al. Occipital nerve stimulation for the treatment of chronic cluster headache - lessons learned from 18 months experience. Cen Eur Neurosurg. May 2011;72(2):84-89. PMID 21448856 11. Fontaine D, Blond S, Lucas C, et al. Occipital nerve stimulation improves the quality of life in medicallyintractable chronic cluster headache: Results of an observational prospective study. Cephalalgia. Oct 03 2016. PMID 27697849 12. Leone M, Proietti Cecchini A, Messina G, et al. Long-term stimulation for drug-resistant chronic cluster headache. Cephalalgia. Jun 01 2016. PMID 27250232 13. Miller S, Watkins L, Matharu M. Treatment of intractable chronic cluster headache by stimulation: a cohort of 51 patients. Eur J Neurol. Feb 2017;24(2):381-390. PMID 27995704 14. Vadivelu S, Bolognese P, Milhorat TH, et al. Occipital nerve stimulation for refractory headache in the Chiari malformation population. Neurosurgery. Jun 2012;70(6):1430-1436; discussion 1436-1437. PMID 22418582 15. Sweet JA, Mitchell LS, Narouze S, et al. Occipital nerve stimulation for the treatment of patients with medically refractory occipital neuralgia: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline. Neurosurgery. Sep 2015;77(3):332-341. PMID 26125672 16. National Institute for Health and Care Excellence. Occipital nerve stimulation for intractable chronic migraine [IPG452]. 2013; https://www.nice.org.uk/guidance/ipg452. Accessed March 11, 2017. Document Precedence Blue Cross and Blue Shield of Vermont (BCBSVT) Medical Policies are developed to provide clinical guidance and are based on research of current medical literature and review of common medical practices in the treatment and diagnosis of disease. The applicable group/individual contract and member certificate language determines benefits that are in effect at the time of service. Since medical practices and knowledge are constantly evolving, BCBSVT reserves the right to review and revise its medical policies periodically. To the extent that there may be any conflict between medical policy and contract language, the member s contract language takes precedence. Audit Information BCBSVT reserves the right to conduct audits on any provider and/or facility to ensure compliance with the guidelines stated in the medical policy. If an audit identifies instances of non-compliance with this medical policy, BCBSVT reserves the right to recoup all noncompliant payments. Page 2 of 6

Benefit Determination Guidance Administrative and Contractual Guidance Prior approval is required for services as outlined in this policy. Benefits are subject to all terms, limitations and conditions of the subscriber contract. Incomplete authorization requests may result in a delay of decision pending submission of missing information. To be considered compete, see policy guidelines above. An approved referral authorization for members of the New England Health Plan (NEHP) is required. A prior approval for Access Blue New England (ABNE) members is required. NEHP/ABNE members may have different benefits for services listed in this policy. To confirm benefits, please contact the customer service department at the member s health plan. Federal Employee Program (FEP): Members may have different benefits that apply. For further information please contact FEP customer service or refer to the FEP Service Benefit Plan Brochure. It is important to verify the member s benefits prior to providing the service to determine if benefits are available or if there is a specific exclusion in the member s benefit. Coverage varies according to the member s group or individual contract. Not all groups are required to follow the Vermont legislative mandates. Member Contract language takes precedence over medical policy when there is a conflict. If the member receives benefits through an Administrative Services Only (ASO) group, benefits may vary or not apply. To verify benefit information, please refer to the member s employer benefit plan documents or contact the customer service department. Language in the employer benefit plan documents takes precedence over medical policy when there is a conflict. Policy Implementation/Update information 2011 New policy 11/2015 Adoption of BCBSA MPRM# 7.01.125. Code table updates. 11/2017 Updated policy/references from BCBSA MPRM# 7.01.125. Policy statements remain unchanged. Added descriptor to code L8689 added to PA list. 06/2018 Updated policy/references from BCBSA MPRM# 7.01.125. Policy statements remain unchanged. Eligible providers Qualified healthcare professionals practicing within the scope of their license(s). Page 3 of 6

Approved by BCBSVT Medical Director(s) Date Approved Joshua Plavin, MD, MPH, MBA Chief Medical Officer Attachment I CPT & Code Table & Instructions Code Type Number Description Policy Instructions The following codes will be denied as Not Medically Necessary, Contract Exclusions or Investigational. CPT 61885 Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array CPT 61886 CPT 64553 CPT 64568 CPT 64569 CPT 64570 Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to 2 or more electrode arrays Percutaneous implantation of neurostimulator electrode array; cranial nerve Incision for implantation of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator Revision or replacement of cranial nerve (eg, vagus nerve) neurostimulator electrode array, including connection to existing pulse generator Removal of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator Page 4 of 6

L8680 Implantable neurostimulator electrode, each L8681 Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only L8682 Implantable neurostimulator radiofrequency receiver L8683 Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver L8685 generator, single array, rechargeable, includes extension L8686 generator, single array, nonchargeable, includes extension L8687 generator, dual, array, rechargeable, includes extension L8688 generator, dual array, norechargeable, includes extension Page 5 of 6

L8689 External recharging system for battery (internal) for use with implantable neurostimulator, replacement only The following code is unlisted and requires clinical documentation at time of claims submission. Clinical documentation will be reviewed and coverage determination will be made by a medical director. CPT 64999 Unlisted procedure, nervous system Clinical documentation is required at time of claims submission for medical review. Page 6 of 6